Search
Data
Data on COVID-19 vaccination in the EU/EEA
Data in various file formats with information on COVID-19 vaccine doses administered, manufacturers, and target groups in the EU/EEA.
Publication
Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries
This pilot protocol is primarily intended to guide the implementation of a first pilot ECDC-funded study using routinely collected data, and includes a concise overview of the systems of the countries included in the pilot study.
Publication
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
This report provides an updated overview of the progress with national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on overall vaccine uptake and uptake by target group vaccination strategies and policies.
News
COVID-19: recommendations on use of adapted vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement (link) providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns.
Publication
Long-term qualitative scenarios and considerations of their implications for preparedness and response to the COVID-19 pandemic in the EU/EEA
This document sets out a number of scenarios that are intended to be plausible, internally consistent, and coherent descriptions of possible futures.
News
Postcard from the field: Deployment during the COVID-19 pandemic: Supporting vaccine effectiveness study implementation in the Republic of North Macedonia
Postcard from the field by Andreas Rohringer, EUPHEM cohort 2020.
Publication
Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA
This protocol outlines the methods for a prospective cohort study in long-term care facilities (LTCFs) to evaluate the effectiveness of COVID-19 vaccines in preventing laboratory-confirmed SARS-CoV-2 symptomatic infection in LTCF residents.
News
Update on the polio situation in the EU/EEA and the world
Globally, as of 9 August, 19 cases of polio due to wild poliovirus type 1 (WPV1) and 223 cases due to circulating vaccine derived poliovirus (cVDPV) have been reported this year. In 2022, the cVDPV cases have been reported in 15 countries, with 93% of the cases attributed to cVDPV type 2 (cVDPV2).
Publication
Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022
This document offers an overview of the available scientific and epidemiological evidence and provides public health considerations to support decisions on the implementation of additional booster doses of COVID-19 vaccine.
News
Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have updated public health recommendations on the use of additional booster doses of COVID-19 vaccines this summer and in the upcoming autumn and winter seasons.